- Home
- ATRA vs MDCX Comparison
ATRA vs MDCX Comparison
Compare ATRA & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- MDCX
- Stock Information
- Founded
- ATRA 2012
- MDCX 2008
- Country
- ATRA United States
- MDCX Canada
- Employees
- ATRA N/A
- MDCX N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- MDCX
- Sector
- ATRA Health Care
- MDCX
- Exchange
- ATRA Nasdaq
- MDCX Nasdaq
- Market Cap
- ATRA 42.9M
- MDCX 48.4M
- IPO Year
- ATRA 2014
- MDCX N/A
- Fundamental
- Price
- ATRA $7.27
- MDCX $4.59
- Analyst Decision
- ATRA Buy
- MDCX Strong Buy
- Analyst Count
- ATRA 5
- MDCX 2
- Target Price
- ATRA $17.75
- MDCX $17.00
- AVG Volume (30 Days)
- ATRA 45.5K
- MDCX 56.7K
- Earning Date
- ATRA 05-20-2025
- MDCX 01-01-0001
- Dividend Yield
- ATRA N/A
- MDCX N/A
- EPS Growth
- ATRA N/A
- MDCX N/A
- EPS
- ATRA N/A
- MDCX N/A
- Revenue
- ATRA $128,940,000.00
- MDCX N/A
- Revenue This Year
- ATRA N/A
- MDCX N/A
- Revenue Next Year
- ATRA N/A
- MDCX N/A
- P/E Ratio
- ATRA N/A
- MDCX N/A
- Revenue Growth
- ATRA 1404.02
- MDCX N/A
- 52 Week Low
- ATRA $5.01
- MDCX $1.80
- 52 Week High
- ATRA $18.71
- MDCX $4.99
- Technical
- Relative Strength Index (RSI)
- ATRA 53.01
- MDCX N/A
- Support Level
- ATRA $6.90
- MDCX N/A
- Resistance Level
- ATRA $8.65
- MDCX N/A
- Average True Range (ATR)
- ATRA 0.63
- MDCX 0.00
- MACD
- ATRA 0.03
- MDCX 0.00
- Stochastic Oscillator
- ATRA 44.58
- MDCX 0.00
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.